Mindstate Design Labs Patents

Patent portfolio assigned to Mindstate Design Labs (verified via public assignee records). Estimated patent count: 1. Preclinical psychedelics/biotech (San Francisco, US; formerly Kykeon Biotechnologies). Drug-development stage with no commercial customers and no clear named direct competitors to source. Patent confirmed: WO2023172701A2 assignee Mindstate Design Labs Inc (entactogenic mindstate compositions). Count is at least 1 visible.